CompletedNot a drug-phase studyMS (type not specified)NCT06264336

What it found

Result in a paper, not read yet

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • treadmill training

What it measured

Main measures

  • Symptomatic fatigue

    Immediately (within 1 week) before and after training

    Fatigue
  • Walking speed

    Immediately (within 1 week) before and after training

    Walking and mobility
  • Corticomotor excitability

    Immediately (within 1 week) before and after training

    Myelin repairNerve conduction tests

Other measures (5)

  • Fatigue impact

    Immediately (within 1 week) before and after training

    Thinking and memoryFatigue
  • Walking endurance

    Immediately (within 1 week) before and after training

    Walking and mobility
  • Aerobic capacity

    Immediately (within 1 week) before and after training

    Physical function
  • Visual processing speed

    Immediately (within 1 week) before and after training

    Thinking and memory
  • Verbal learning and memory

    Immediately (within 1 week) before and after training

    MRI lesionsThinking and memory

Who could take part

MS (type not specified) · 21 and over

Inclusion Criteria: * Age ≥21 years * Multiple sclerosis diagnosis * Stable disease-modifying therapy (DMT) over the past 6 months * Walking dysfunction (i.e., abnormal gait pattern, Expanded Disability Status Scale (EDSS) score of 4-6.5, and/or Patient-determined disease steps (PDDS) score of 3-6) * Able to walk for 6 minutes at self-paced speed. Handheld assistive device is acceptable. * Symptomatic fatigue (Fatigue Severity Score ≥ 4) Exclusion Criteria: * Adults unable to consent * Pregnant women * Prisoners * Multiple sclerosis relapse within the last 30 days * Other neurological disorders besides multiple sclerosis * Cardiorespiratory or metabolic diseases (e.g., cardiac arrhythmia, uncontrolled hypertension or diabetes, chronic emphysema) * Significant cognitive or communication impairment (Mini-Mental State Examination (MMSE)\<21), which could impede the understanding of the purpose of procedures of the study or prevent the patient from performing the ankle-tracking task. * Severe osteoporosis * Failure to pass the graded exercise stress test * Implanted cardiac pacemaker * Metal implants in the head or face * Unexplained, recurring headaches * History of seizures or epilepsy * Currently under medication that could increase motor excitability and lower seizure threshold * Skull abnormalities or fractures * Concussion within the last 6 months

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Nearly 1 million individuals in the United States have multiple sclerosis, which causes fatigue and problems with walking. Fatigue and walking problems are poorly treated, but exercise training, particularly high-intensity walking exercise, may help. This provide insight into whether high-intensity walking exercise can improve fatigue and walking problems in people with multiple sclerosis, which could improve quality of life and reduce economic burden.

Papers

Loading reviews and guidelines…

History

    1. Started

      Mar 2024

    2. Main results due

      Mar 2026

    3. Finished

      Mar 2026

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error